Press Releases | DEA.gov
Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
      • Domestic Divisions
      • Foreign Divisions
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • What We Do
    • Forensic Sciences
      • GUARDS
      • Forensic Sciences Policy
      • Forensic Science Organizations
      • Forensic Science Contact
    • Law Enforcement
      • DEA Office of Training
        • Office of Training Programs
      • El Paso Intelligence Center (EPIC)
      • Intelligence
      • Operations
        • Administrative Law Judges
        • DEA Asset Forfeiture
        • Domestic Cannabis Suppression / Eradication Program
        • HIDTA
        • OCDETF
    • Education and Prevention
      • Family Summit
      • Red Ribbon
      • Kiki and the History of Red Ribbon Week
      • Red Ribbon Toolkit - Resources For Your Community
      • DEA’s Family Summit
      • Operation Engage
      • Community Outreach
      • Just Think Twice
      • Campus Drug Prevention
      • Get Smart About Drugs
      • Operation Prevention
    • Drug Information
      • Drug Policy
      • Drug Scheduling
      • The Controlled Substances Act
    • News
      • Alerts
      • Press Releases
      • Most Wanted Fugitives
        • All Fugitives
      • Stories
      • Events
      • Speeches
      • Testimony
    • Campaigns
      • One Pill Can Kill
        • Senior Citizens
        • Partner Toolbox
        • Social Media Campaign
      • DEA National Prescription Drug Take Back Day
  • Careers
    • Special Agent
      • Special Agent FAQs
    • Diversion Investigator
      • Diversion Investigator Job Announcement
    • Intelligence Research Specialist
      • Intelligence Research Specialist Job Announcements
      • Intelligence Research Specialists FAQs
      • Schedule A Hiring Authority: Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
      • How To Claim Veterans' Preference
      • Priority Consideration
      • Benefits
      • Veterans and People With Disabilities
      • Operation Warfighter
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
      • Domestic Arrests
      • Staffing and Budget
    • FOIA
      • About FOIA
      • Contact DEA FOIA
      • Make a Request
      • What Happens After Making a Request
      • Requester Categories
      • Fees Charged
      • Fee Waiver
      • FOIA FAQ
      • FOIA Logs and Reports
      • FOIA Library
      • Additional FOIA Links
      • FOIA Exemptions
      • What Are Exclusions?
      • Privacy Act
      • Privacy Act Exemptions
      • Privacy Impact Assessment and Management Information Systems
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
      • Victim Witness Assistance Program Resources
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Get Updates
  • Scam Alert
  • Full Menu
  • English
  • Español

Main Menu

Explore DEA
  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Education and Prevention
    • Drug Information
    • News
    • Campaigns
  • Careers
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
    • FOIA
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
  • Submit A Tip

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2026 (5)
  • 2025 (26)
  • 2024 (37)
  • 2023 (48)
  • 2022 (54)
  • 2021 (116)
  • 2020 (82)
  • 2019 (77)
  • 2018 (87)
  • 2017 (86)
  • 2016 (52)
  • 2015 (39)
  • 2014 (52)
  • 2013 (57)
  • 2012 (19)
  • 2011 (65)

Subject

  • Drug Trafficking (104)
  • Guns/Weapons (42)
  • Prescription Drugs (38)
  • Arrests/Convictions - Major (37)
  • Guilty Plea (36)
  • Synthetic drugs (36)
  • Take Back Day (35)
  • HIDTA (28)
  • Gangs (25)
  • Outreach/Drug Prevention (25)
  • Diversion Division (24)
  • OCDETF/Task Force (22)
  • Fake Pills (21)
  • Seizures (Drugs/Property) (21)
  • Major Law Enforcement Operation (20)
  • Pharmaceuticals/Pharmacists/Physicians (20)
  • Public and Media Affairs - also see Congressional Affairs (20)
  • Task Forces/Task Force Officers (20)
  • Press Conferences (17)
  • Money Laundering (16)
  • Fentanyl Awareness (13)
  • Congressional Affairs (12)
  • Prevention/Education - DEA websites GSAD, JTT etc (12)
  • One Pill Can Kill (9)
  • Red Ribbon (9)
  • International/Foreign Operations (8)
  • Overdose (7)
  • Extraditions (6)
  • Intergovernmental Affairs (5)
  • Narcoterrorism (4)
  • Counterfeit Pills (3)
  • Critical Incident (3)
  • Dark Web- Internet Trafficking (3)
  • Fentanyl Free America (3)
  • Terrorism (3)
  • Campaigns (2)
  • Scam Calls (2)
  • Intelligence Division - Intelligence Products (1)
  • Museum and Visitors Center (1)
  • Other (1)

Drug Name

  • Fentanyl (94)
  • Cocaine (76)
  • Heroin (62)
  • Methamphetamine (39)
  • Oxycodone (11)
  • Marijuana (Cannabis) (10)
  • Opioids (7)
  • Synthetic Opioids (6)
  • Ecstasy/MDMA (2)
  • Marijuana Concentrates (2)
  • GHB (1)
  • Ketamine (1)
  • Psilocybin (1)
  • Steroids (1)

Field Division

  • New England (2385)
  • New York (1521)
  • Houston (907)
  • San Francisco (847)
  • Miami (840)
  • Seattle (812)
  • St. Louis (808)
  • Atlanta (777)
  • Chicago (629)
  • Washington, DC (617)
  • New Orleans (481)
  • Detroit (361)
  • El Paso (350)
  • Dallas (315)
  • Los Angeles (300)
  • Phoenix (274)
  • San Diego (246)
  • Rocky Mountain (166)
  • Philadelphia (140)
  • Omaha (137)
  • Louisville (81)
  • Caribbean (79)
  • Caribbean (1)
  • New Jersey (493)
  • Headquarters (414)
Clear All Results
902 Results - Showing 111 to 120
PRESS RELEASE

California Men Admit Conspiring to Distribute Fentanyl and Meth

NEWARK, N.J. – Acting Special Agent in Charge of the Drug Enforcement Administration’s New Jersey Division Daniel J. Kafafian and U.S. Attorney for the District of New Jersey Philip R. Sellinger announced two California men admitted conspiring to distribute and possess with intent to distribute fentanyl and methamphetamine in New...
PRESS RELEASE

Charges Unsealed Against Specially Designated Global Terrorist Mohammad Bazzi and Talal Chahine

BROOKLYN, N.Y. – A three-count indictment was unsealed today in United States District Court for the Eastern District of New York charging Mohammad Ibrahim Bazzi, a Lebanese and Belgian citizen, and Talal Chahine, a Lebanese citizen, with conspiracy to conduct and cause United States persons to conduct unlawful transactions with...
PRESS RELEASE

DEA Announces Proposed Rules for Permanent Telemedicine Flexibilities

WASHINGTON - Today, the Drug Enforcement Administration announced proposed permanent rules for the prescribing of controlled medications via telemedicine, expanding patient access to critical therapies beyond the scheduled end of the COVID-19 public health emergency. The public will be able to comment for 30 days on the proposed rules. The...
PRESS RELEASE

Former Office Manager of New Jersey Medical Practice Admits Conspiring with Doctor to Divert Controlled Substances

NEWARK, N.J. – Acting Special Agent in Charge of the Drug Enforcement Administration’s New Jersey Division Daniel J. Kafafian and U.S. Attorney for the District of New Jersey Philip R. Sellinger announced a former office manager of a New Jersey medical practice admitted conspiring with the doctor who owned the...
PRESS RELEASE

Hudson County Man Sentenced to 51 Months in Prison for Drug Conspiracy and Possession with Intent to Distribute Cocaine

NEWARK, N.J. – Acting Special Agent in Charge of the Drug Enforcement Administration’s New Jersey Division Daniel J. Kafafian and U.S. Attorney for the District of New Jersey Philip R. Sellinger announced a Hudson County, New Jersey, man was sentenced to 51 months in prison for conspiring to distribute and...
PRESS RELEASE

Nine Men Charged with Roles in Gang-Led Drug and Gun Trafficking Network

NEWARK, N.J. – Acting Special Agent in Charge of the Drug Enforcement Administration’s New Jersey Division Daniel J. Kafafian, Acting Special Agent in Charge of the Bureau of Alcohol, Tobacco, Firearms, and Explosives Newark Field Division Bryan R. Miller, and U.S. Attorney for the District of New Jersey Philip R...
PRESS RELEASE

Department of Justice Files Nationwide Lawsuit Against Amerisource Bergen Corp. and Subsidiaries for Controlled Substances Act Violations

NEWARK, N.J. – In a civil complaint filed today, the Department of Justice alleges that AmerisourceBergen Corp. and two of its subsidiaries, AmerisourceBergen Drug Corp. and Integrated Commercialization Solutions LLC (AmerisourceBergen), collectively one of the country’s largest wholesale pharmaceutical distributors and one of the largest companies in America by revenue...
PRESS RELEASE

Drug Enforcement Administration Announces the Seizure of Over 379 million Deadly Doses of Fentanyl in 2022

WASHINGTON – As 2022 comes to an end, the Drug Enforcement Administration is announcing the seizure of over 50.6 million fentanyl-laced, fake prescription pills and more than 10,000 pounds of fentanyl powder this calendar year. The DEA Laboratory estimates that these seizures represent more than 379 million potentially deadly doses...
PRESS RELEASE

DEA Serves Order to Show Cause on Truepill Pharmacy for its Involvement in the Unlawful Dispensing of Prescription Stimulants

WASHINGTON -- Today, DEA served an Order to Show Cause on Truepill, a retail pharmacy that is alleged to have wrongfully filled thousands of prescriptions for stimulants used in the treatment of Attention Deficit/Hyperactivity Disorder (ADHD). Truepill was the pharmacy for telehealth companies, including Cerebral, that marketed ADHD treatments, including...
PRESS RELEASE

Operation Florida Keys Results in 16 Arrests and Seizure of Drugs, Guns, and Cash

ATLANTIC CITY, N.J. – Special Agent in Charge of the Drug Enforcement Administration’s New Jersey Division Susan A. Gibson, Police Chief of the Atlantic City PD James A. Sarkos, Atlantic County Prosecutor William Reynolds, and Executive Director of the Liberty Mid-Atlantic HIDTA Jeremiah Daley announced a months-long investigation into the...

Pagination

  • First page «
  • Previous
  • Page 8
  • Page 9
  • Page 10
  • Page 11
  • Current page 12
  • Page 13
  • Page 14
  • Page 15
  • Page 16
  • Next
  • Last page »
  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Drug Prevention
    • Diversion Control Division
    • News
  • Careers
    • Special Agent
    • Diversion Investigator
    • Forensic Sciences
    • Intelligence Research Specialist
    • How to Apply
  • Resources
    • Drug Information
    • Employee Assistance Program
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
    • Vendor Engagement Request
  • Policies
    • Accessibility & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster